

Angle's Parsortix Able To Predict Patients' Response To Treatment


IN BRIEF: Angle Notes Study Showing "Key Capabilities" Of Parsortix


(Sharecast News) - Angle announced on Monday that the University of Southern California (USC) has published peer-reviewed results of new work undertak...


Angle Progresses On Parsortix And De Novo Clearance From US Regulator


UK Earnings, Trading Statements Calendar - Next 7 Days


IN BRIEF: Haydale Graphene Appoints Former AIM Market COO To Board


Angle's Parsortix Could Be Used To Pick MET Inhibitor Trial Subjects


(Sharecast News) - Liquid biopsy company Angle announced on Tuesday that the liquid biopsy analysis unit at the Health Research Institute of Santiago ...